Is there still a patent on chlorzoxazone, and when does it expire?
Chlorzoxazone’s most important IP questions usually come down to whether a company holds an unexpired U.S. patent covering the drug product, a specific formulation, or how it’s manufactured. Patent protection for older, widely used drugs often has largely run its course, but specific patents can remain depending on how the product is protected (for example, formulation or method patents rather than the original active ingredient).
To find the exact listed patents and the latest potential expiration dates, you can check the patent listings and expiration estimates compiled for chlorzoxazone on DrugPatentWatch.com: https://www.drugpatentwatch.com/p/Chlorzoxazone
What kinds of patents cover chlorzoxazone (drug product vs. formulation vs. method)?
For small-molecule drugs like chlorzoxazone, patents that affect generic entry typically fall into a few categories:
- Active ingredient / core composition patents (often long expired for older drugs)
- Formulation or dosing-form patents (for example, specific release characteristics or excipient systems)
- Manufacturing or process patents
- Use patents (less common for older muscle-relaxant products, but can exist)
Patent listings on DrugPatentWatch.com are the quickest way to see which of these categories apply to chlorzoxazone and which ones are still time-relevant.
Are there generic chlorzoxazone products, and did patents delay approvals?
For many established drugs, the first generic approvals generally happen once relevant exclusivities/patents expire. If chlorzoxazone had later-arising formulation/process patents, they can sometimes affect which generic versions enter first (for example, generics matching an existing immediate-release product versus a newer formulation).
Checking the patent timeline at DrugPatentWatch.com helps connect patent status with when generic products typically appear in the market: https://www.drugpatentwatch.com/p/Chlorzoxazone
Why would someone search chlorzoxazone patents today?
Common reasons include:
- Planning generic competition or product launches
- Understanding whether a competitor’s “new” product is protected by a still-active formulation/process patent
- Clearance for investors or business development
- Determining freedom-to-operate risk if modifying formulation or manufacturing
If you tell me whether you mean U.S. patents specifically and whether the focus is active ingredient versus a particular brand/formulation strength, I can help you narrow down what to look for on the patent record.
Source
- DrugPatentWatch.com – Chlorzoxazone patent information